Advertisement

Parkinson-Syndrom:Lebenserwartung und Lebensqualität — Realität versus Patientensicht

  • L. Lachenmayer
Conference paper
  • 69 Downloads

Zusammenfassung

Ein Parkinson-Syndrom ist eine progredient verlaufende Krankheit, die im Spät-stadium erhebliche Behinderungsgrade bewirken kann. Die prognostische Beurteilung eines individuellen Verlaufs ist schwierig, erfordert aber in jedem Fall zunächst eine exakte differenzialdiagnostische Einordnung. Die idiopathische Parkinsonkrankheit muss von anderen degenerativen Prozessen (ParkinsonPlus-Syndromen) abgegrenzt werden [8]. Diagnostische Kriterien für das Vorliegen einer idiopathischen Parkinsonkrankheit sind gut validiert (sog. Londonbrain-bank-Kriterien; siehe Tabelle 1). Auch für die häufigsten Parkinson-PlusSyndome (siehe Tabelle 2) liegen international akzeptierte Kriterien vor [29].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51: 745–752PubMedCrossRefGoogle Scholar
  2. 2.
    Gilman S, Low P, Quinn N (1998) Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 8: 359–362PubMedCrossRefGoogle Scholar
  3. 3.
    Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442PubMedCrossRefGoogle Scholar
  4. 4.
    Horowski R, Horowsk L, Vogel S, Poewe W, Kielhorn FW (1995) An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson’s disease by a patient. Neurology 45: 565–568PubMedCrossRefGoogle Scholar
  5. 5.
    Humboldt W von (1986) Briefe an eine Freundin. Lindner J (Hrsg) Verlag der Nation, BerlinGoogle Scholar
  6. 6.
    Jankovic J, Kapadia AS (2001) Funcional decline in Parkinson’s disease. Arch Neurol 58: 1611–1615PubMedCrossRefGoogle Scholar
  7. 7.
    Kostic V, Przedborski S, Flaster E, Sternic N (1991) Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson’s disease. Neurology 41: 202–205PubMedCrossRefGoogle Scholar
  8. 8.
    Lachenmayer L, Arning C, Reichmann H (2002) Frith-und Differenzialdiagnose der Parkinson-Syndrome. Nervenheilkunde 21: 38–45Google Scholar
  9. 9.
    Lakke JPWF (1996) Wilhelm von Humboldt and James Parkinson. An appraisal of observation and creativity. Parkinsonism and Related Disorders 2: 225–229PubMedCrossRefGoogle Scholar
  10. 10.
    Leplow B (1998) Psychologische und psychosoziale Aspekte beim Parkinson-Syndrom. Psycho 24: 554–559Google Scholar
  11. 11.
    Litvan I, Agid Y, Caine D (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9PubMedCrossRefGoogle Scholar
  12. 12.
    Martinez-Martin P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo, JL, Rumia J, Ferrer E (2002) Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 17: 372–377PubMedCrossRefGoogle Scholar
  13. 13.
    McKeith IG, Galasko D, Kosaka K (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124PubMedCrossRefGoogle Scholar
  14. 14.
    McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Neurology 53: 902–905PubMedCrossRefGoogle Scholar
  15. 15.
    Morrish P (2002) Is it time to abandon functional imaging in the study of neuroprotection? Mov Disord 17: 229–232PubMedCrossRefGoogle Scholar
  16. 16.
    Muller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55: 888–891PubMedCrossRefGoogle Scholar
  17. 17.
    Myslobodsky M, Lalonde FM, Hicks L (2001) Are patients with Parkinson’s disease suicidal? J Geriatr Psychiatry Neurol 14: 120–124PubMedCrossRefGoogle Scholar
  18. 18.
    Olanow CW, Watts RL, Koller WC (2001) An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines. Neurology 56 (Suppl 5)Google Scholar
  19. 19.
    Palmer CS, Schmier JK, Snyder E, Scott B (2000) Patient preferences and utilities for “off-time” outcomes in the treatment of Parkinson’s disease. Quality of Life Res 9: 819–827CrossRefGoogle Scholar
  20. 20.
    Parkinson Study Group (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA 284: 1931–1938CrossRefGoogle Scholar
  21. 21.
    Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287: 1653–1661CrossRefGoogle Scholar
  22. 22.
    Poewe W, Seppi K (2001) Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 248 (Suppl 3): 12–21CrossRefGoogle Scholar
  23. 23.
    Poewe WH, Wenning GK (1996) The natural history of Parkinson’s disease. Neurology 47 (Suppl 3): S146–152PubMedCrossRefGoogle Scholar
  24. 24.
    Pollak P, Fraix V, Krack P, Moro E, Mendes A, Chabardes S, Koudsie A, Benabid AL (2002) Treatment results: Parkinson’s disease. Mov Disord 17 (Suppl 3): S75–83PubMedCrossRefGoogle Scholar
  25. 25.
    Rascol 0, Brooks DJ, Korczyn AD, DeDeyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. NEJM 342: 1484–1491PubMedCrossRefGoogle Scholar
  26. 26.
    Rascol 0, Goetz C, Koller W, Poewe W, Sampaio C (2002) Treatment interventions for Parkinson’s disease: an evidence based assessment. Lancet 359: 1589–1598PubMedCrossRefGoogle Scholar
  27. 27.
    Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15: 1112–1118PubMedCrossRefGoogle Scholar
  28. 28.
    Watts RL, Mirra SS, Richardson EP (1994) Corticobasal ganglionic degheneration. In: Marsden CD, Fahn S (eds) Movement Disorders. Butterworths-Heinemann, LondonGoogle Scholar
  29. 29.
    Wenning GK, Michlmayr S, Braune S, Brüke T, Fogel W, Gerster P, Schulz JB, Volkmann J (2001) Empfehlungen zur Differenzialdiagnose von Parkinson-Syndromen. Akt Neurol 28: 256–260CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • L. Lachenmayer

There are no affiliations available

Personalised recommendations